SERPINA3 and tuberculosis: In the independent blind test, we validated the diagnostic accuracy of the ACT-AGP1-CDH1 combination with identification of PTB patients (n = 28) and non-TB individuals, including LTBI individuals (n = 26), HCs (n = 26) and LC patients (n = 33).